Novartis AG is 28.0x more valuable than Summit Therapeutics Inc. by market capitalization ($283.13 B vs $10.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SMMT | NVS |
|---|---|---|
| Market cap | $10.13 B | $283.13 B |
| US-listed rank | #935 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$1.08B | - |
| SEC filings | 532 | 947 |
Novartis AG is 28.0x more valuable than Summit Therapeutics Inc. by market capitalization ($283.13 B vs $10.13 B).
Full pages: Summit Therapeutics Inc. and Novartis AG, or browse the full rankings.